Podcasts about pharmacopeia

What does it take to deliver impactful learning in a global, highly regulated industry? Tim Greiner, Senior Director of USP Education at the U.S. Pharmacopeia, a global nonprofit that sets quality standards for medicines, food, and dietary supplements, shares how USP delivers education at scale to ensure those standards are applied effectively across industries and regions to improve quality and protect public health. Show Notes:Senior Education Director Tim Greiner explains how USP delivers training that improves quality and performance. Key takeaways from the conversation include:Impact over completion: In regulated environments, training success is measured by behavior change and improved quality practices—not just course completion. Design for diverse, global audiences: Effective programs balance modalities, regional preferences, and roles (regulators, manufacturers, students) without overcomplicating delivery. Blended learning drives stronger outcomes: Live and live-virtual experiences tend to have the highest impact, especially when paired with self-paced resources for reinforcement. Operational discipline matters at scale: Managing global training requires strong processes—centralized content, regular reviews, and alignment with evolving standards. Microlearning in the flow of work is the future: Delivering targeted learning at the exact moment of need can significantly increase retention, application, and overall impact. Powered by Learning earned Awards of Distinction in the Podcast/Audio and Business Podcast categories from The Communicator Awards and a Gold and Silver Davey Award. The podcast is also named to Feedspot's Top 40 L&D podcasts and Training Industry's Ultimate L&D Podcast Guide. Learn more about d'Vinci at www.dvinci.com. Follow us on LinkedInLike us on Facebook

Shareholder Advocacy in 2026: A Season Defined by Upheaval and Resilience *A deeper look at the key themes and proposals in the Proxy Preview 2026 report by As You Sow and Proxy Impact* The 2026 proxy season is arriving amid one of the most turbulent regulatory environments shareholder advocates have faced in decades. Actions by the Securities and Exchange Commission (SEC) under Chair Paul Atkins have introduced a series of new barriers to shareholder participation — limiting who can file resolutions, restricting exempt solicitations on EDGAR, and signaling a broader retreat from the corporate disclosure requirements that have defined the modern era of investor oversight. Filing thresholds have been quietly tightened. The procedural goalposts have moved. And the agency that once served as a neutral referee on what does and does not belong on a proxy ballot has, in practice, stepped off the field. And yet, shareholders are not retreating. As Proxy Preview publisher Andrew Behar puts it, they are “standing shoulder to shoulder” — the early warning system that corporations have long relied on, whether they admit it or not. The proposals filed this year are, if anything, more ambitious than in seasons past. Investors are not waiting to see how the regulatory landscape settles. They are filing, litigating, and engaging on the assumption that the right to ask questions about material risk is theirs to exercise regardless of who chairs the SEC. This year’s Proxy Preview, produced by As You Sow and Proxy Impact, offers a sweeping look at the environmental, social, and governance (ESG) proposals headed to shareholder votes in 2026. The themes range from the data center buildout reshaping America’s electricity grid, to the legal liabilities mounting against Big Tech, to the quiet but consequential question of who gets to decide what counts as “proper business” at an annual meeting. Here’s what investors need to know. The Political and Legal Backdrop The story of the 2026 season cannot be told without first addressing what happened to the SEC’s no-action process. Historically, when a company wanted to exclude a shareholder proposal from its proxy statement, it would file a no-action request with the SEC, which would review the proposal on its merits and issue guidance. That process — imperfect but functional — was effectively suspended this year, triggered in part by a prolonged government shutdown that left the agency without the bandwidth to render decisions. The result was a free-for-all. Companies, sensing an opening, filed notices of intent to exclude proposals on a range of novel theories. The most aggressive of these was the so-called “Delaware Proper Business” argument, which holds that advisory shareholder proposals — the non-binding resolutions that have been the backbone of shareholder advocacy for decades — are not “proper business” for an annual meeting under Delaware corporate law. If accepted, that theory would effectively wipe out the entire category. Shareholders pushed back, hard. Lawsuits were filed against AT&T, Axon, Chubb, BJ’s Wholesale, and PepsiCo. AT&T and Pepsi settled quickly, restoring the proposals to their proxies. At Axon, a federal court ordered the parties to explore a negotiated resolution rather than rule on the merits — a signal that judges are skeptical of the broad exclusion theories companies have been advancing. The Chubb and BJ’s cases remain in active litigation as of this writing. Meanwhile, in a parallel front, a federal court struck down Texas Senate Bill 13 — the state’s anti-ESG law that restricted public pension funds from doing business with financial firms deemed to “boycott” fossil fuel companies — as unconstitutionally overbroad and vague. It is the first federal court decision to invalidate this type of statute, and it sets up a potential precedent that could unwind similar laws in roughly a dozen other states. The pattern, taken together, is clear. Where companies and state legislatures have tried to use procedural and legal tools to silence shareholder voice, the courts have so far been unwilling to go along. Climate: Data Centers, Stranded Assets, and Insurance If there is one new climate story dominating the 2026 season, it is the AI buildout. The numbers are striking. In 2025, the number of proposed fossil gas plants in the U.S. nearly tripled, driven almost entirely by soaring electricity demand from new data centers. Utilities that had been quietly retiring coal and gas capacity are now reversing course, citing grid commitments to hyperscale tech customers as the rationale. Investors are responding. Proposals at Amazon, Meta, and Alphabet request disclosure on how the companies’ growing data center operations are compatible with their previously announced climate commitments — many of which include net-zero pledges that look increasingly difficult to reconcile with multi-gigawatt computing expansion. Similar proposals target the utility side of the equation, including Dominion Energy and Southern Company, both of which are major suppliers to data center hubs in Virginia and Georgia. At the same time, the U.S. is in the middle of a climate-driven insurance crisis that is starting to attract serious investor attention. Insured natural-catastrophe losses reached $117 billion in 2024 — more than double the ten-year average. Homeowners insurance premiums rose 24% between 2021 and 2024, and entire ZIP codes in California, Florida, and Louisiana have effectively become uninsurable on the private market. As You Sow has filed a novel “subrogation” proposal at Chubb, asking the insurer to explore using subrogation claims against large emitters to offset climate-related losses. The legal theory borrows from the playbook used against tobacco and opioid manufacturers: if you can identify the parties whose conduct caused the harm, you can pursue them for the cost of paying out claims. Climate transition planning remains a critical investor concern more broadly. Proposals at Harley-Davidson and Verizon push these companies — both of which have ambitious net-zero commitments but published no sustainability reports in 2025 — to develop credible, stand-alone transition plans. The implicit argument is that a target without a plan is not a commitment; it is a press release. Biodiversity: Horseshoe Crabs and Avocado Supply Chains Two of the most distinctive proposals this season concern biodiversity, and both illustrate how shareholder advocacy can move industries that regulators have not. The pharmaceutical industry’s dependence on horseshoe crab blood for drug safety testing is under fresh scrutiny. The compound extracted from the crabs — limulus amebocyte lysate, or LAL — is used to detect bacterial endotoxins in injectable drugs and implantable medical devices. Each year, roughly 1.1 million horseshoe crabs are harvested and bled, with the industry historically claiming low post-bleeding mortality. Independent research suggests the actual mortality rate is closer to 30%, with knock-on effects for shorebirds and other species that depend on horseshoe crab eggs as a food source. Synthetic alternatives — recombinant Factor C, or rFC — have been commercially available since 2003 and are used routinely by Eli Lilly and others. The U.S. Pharmacopeia, the standards body that governs pharmaceutical testing in the U.S., updated its standards in November 2024 to place rFC on equal regulatory footing with the animal-derived test. That removes the last meaningful technical barrier to transition. Proposals at Abbott and Merck request disclosure about transition timelines. The avocado story is, in some ways, a more hopeful one — a case study in what sustained shareholder engagement can accomplish over time. Mexican avocado production has long been linked to illegal deforestation, with growers clearing protected forest in Michoacán to plant new orchards. As You Sow’s decade-long push for Pro Forest Avocado (PFA) certification — a satellite-based system that monitors orchards in real time for evidence of land-use change — has transformed the supply chain. As of March 2026, over 60 Mexican avocado packers are PFA-certified, and major U.S. retailers including Costco, Walmart, and Kroger have committed to sourcing from certified suppliers. The notable holdout is Albertsons, which has not responded to repeated engagement requests and is the focus of a 2026 proposal. Social: Human Rights, Surveillance, and Child Safety Big Tech is facing what Michael Passoff of Proxy Impact calls its “Big Tobacco moment” — the period when accumulating evidence of harm crosses the threshold from controversial to legally actionable, and the financial consequences begin to compound. The numbers from the past twelve months are difficult to dismiss. In March 2026, Meta was found guilty of violating New Mexico’s consumer protection law and penalized $375 million for its handling of minors on Instagram. Separately, a California court found Meta and Google guilty of creating addictive platform designs that harm young users’ mental health, in a verdict that is likely to be the template for similar cases in other states. Meta’s stock dropped 8% following the verdicts, suggesting the market is finally beginning to price in legal risk that shareholders have been flagging for years. On surveillance, investors at Alphabet/Google and Home Depot are pressing for oversight of customer and user data. The specific concerns are concrete. Home Depot cameras installed in parking lots have, according to public reporting, enabled ICE raids targeting day laborers. Google was hit with a $425.7 million verdict for tracking 98 million users after they had explicitly turned location tracking off. In both cases, the proposals ask not for the companies to change their business models, but for the boards to take responsibility for the data practices their products create. New this year, and likely to attract significant attention: a proposal at Palantir asking the company to conduct a Human Rights Impact Assessment related to its products and services. The proposal follows reports that Palantir’s software is being used by ICE to track and target migrants, including in operations that have separated families and detained individuals without prior criminal records. Palantir has historically resisted human rights disclosure on the grounds that its government contracts are confidential; the proposal tests whether shareholders can compel disclosure of the broader policy framework even when specific contract terms remain under seal. Political Spending and Lobbying Corporate political spending is under heightened scrutiny as the 2026 midterm elections approach. The Center for Political Accountability (CPA), which has been the leading shareholder voice on this issue for two decades, filed disclosure proposals at 29 companies this proxy season. The proposals ask for disclosure of corporate political contributions, including those made to trade associations and other intermediaries that often serve as a workaround for direct disclosure requirements. What is striking is the response. Despite the SEC’s effective invitation to exclude most shareholder proposals this year, only 7 of the 29 companies chose to do so. The other 22 let the proposals proceed to a vote — a tacit acknowledgment that the political risk of being seen to suppress shareholder voice on political spending now outweighs the cost of disclosure. The CPA proposal averaged 41.4% support over 13 votes in 2025, including five majority votes, putting it well above the threshold at which boards typically engage seriously with proponents. The lobbying disclosure campaign also continues, though with a revised proposal structure following a 2025 setback when the SEC sided with Air Products and Chemicals on a technical exclusion argument. The new, streamlined proposal — focused on direct federal and state lobbying amounts and third-party recipients — is being filed at 7 companies including Goldman Sachs, J.P. Morgan Chase, and Morgan Stanley. The narrower scope is designed to be procedurally bulletproof, leaving the substantive question — should a public company tell its owners how much it spends to influence legislation — on the table for shareholders to answer. Governance: Board Accountability and Executive Pay Several governance proposals this season cut to the question of what boards are actually responsible for. Shareholders are requesting that boards provide specific oversight of AI development, climate change, Indigenous peoples’ rights, and data protection — areas where the gap between executive decision-making and board supervision has become particularly wide. A notable Vote No campaign: NYC Pension Funds, the third-largest public pension system in the country, urged Starbucks shareholders to vote against the re-election of two directors, citing over 700 unfair labor practice charges, 60 adverse administrative law decisions, and the quiet disbanding of a labor relations oversight committee that had been formed in response to earlier shareholder pressure. The campaign is significant not only for its scale but for the specificity of its case: this is not a general grievance about management, but a documented record of regulatory findings the directors are charged with overseeing. A new executive compensation proposal at Meta links CEO and executive bonuses to improvements in child safety metrics — a direct response to the company’s mounting legal liability over platform harms to minors. The proposal is structurally interesting because it does not ask the company to take any specific action; it asks only that the compensation committee tie pay to outcomes the company itself has acknowledged as material. If child safety is, as Meta has repeatedly stated in public, a top priority, then linking executive pay to it should be uncontroversial. The vote will reveal whether the board agrees. The Bottom Line The 2026 proxy season is, more than anything, a test of whether shareholders can maintain their voice in corporate governance amid a hostile regulatory environment. The evidence so far is encouraging. When companies have tried to unilaterally exclude proposals, they have largely faced legal challenges and backed down. When state legislatures have tried to penalize ESG-aligned investing, federal courts have intervened. When boards have tried to ignore mounting legal liability, the markets have begun to do the disciplining themselves. As shareholder advocate Nell Minow writes, the likely cost-benefit analysis from executives “who thought they could keep the proposals from going to a shareholder vote was not clear to them until they faced the very real possibility that a court ruling on the legitimacy of the challenged proposal would be a much bigger problem.” In other words: the bet that the SEC’s retreat would translate into a free hand for management has not paid off. The deterrents have simply moved from the regulator to the courts and the proxy ballot itself. Fundamental ownership rights — the right to ask questions about material risks — are not granted by regulators. They are inherent to ownership itself. The 2026 season is shaping up to be the year that principle gets tested, and so far, it is holding. — *Sources: Proxy Preview 2026, published by As You Sow and Proxy Impact. Full report available at [proxypreview.org](https://www.proxypreview.org/).*

The global medicine supply chain faces mounting strain from chronic generic drug shortages, geopolitical tensions, and heavy reliance on geographically concentrated manufacturing. Quality failures, pricing pressures, and opaque sourcing of key starting materials have exposed structural vulnerabilities that extend beyond routine disruptions to broader national security and public health risks. This episode is part one of a two-part series examining the root causes of these vulnerabilities and the structural changes needed to address them. In this series, we spoke with Ronald T. Piervincenzi, Ph.D., CEO of the U.S. Pharmacopeia, about how these risks emerged and what it will take to build a more resilient pharmaceutical supply chain. In part one, Piervincenzi explains why generic drug shortages and national security concerns are often conflated, how extreme price erosion is driving manufacturers out of the market, and what USP's data reveals about supply concentration, including the critical role of key starting materials sourced from countries like China and India. The conversation also dives into USP's new Resilience Center and the strategic role it will serve in improving supply chain security.

From multivitamins to protein powders, thousands of supplements crowd drugstore shelves offering over-the-counter answers to our nutritional needs. Yet with so many options out there, how do we know which ones to trust?Joining us is US Pharmacopeia (USP), an organization focused on building trust in the supply of safe, trusted quality medicine. USP, is an independent, scientific nonprofit organization focused on building trust in the supply of safe medicines. Through rigorous science and the public quality standards they set, USP helps protect patient safety and improve the health of people around the world.

Soren Shade is a drug researcher known for producing Hamilton's Pharmacopeia on Vice and as the Founder of Kratom leaf tea company Top Tree Herbs.We discuss the evolution of drug markets and policy with a long-view approach beginning in the 1870's and on through today's rapidly shifting drug legislation frameworks globally. Please rate and review this episode wherever you're listening ( : Hosted on Acast. See acast.com/privacy for more information.

The Argonauts have arrived in Colchis, the Golden Fleece is within their reach. But Jason will need the help of the goddess Aphrodite and the sorceress, Medea, to face the challenges ahead. And that help will come at a price. *Sensitive listeners beware - some of this episode is gruesome!* Written and directed by Bibi Jacob. Sound and production by Geoff Chong. Original compositions written and performed by Chloe Dunn - with Louis appearing as Eros.  Featuring: Tom Morton as Aeëtes, Chloe Dunn as Aphrodite, Tercelin Kirtley as Orpheus, Ciaran Cresswell as Jason, Rose Romain as Medea. Sources for this episode include: Apollonius' ‘Argonautica', ‘The Orphic Argonautica', Euripides' ‘Medea', Seneca's ‘Medea', Pinder's 4th Pythian.  The extract from Euripide's ‘Medea' is in a translation by Ian Johnston, Vancouver Island University.

Jack is joined by Hamilton Morris — scientific researcher, documentarian, journalist, and podcaster. Best known for his VICE column-turned-TV series Hamilton's Pharmacopeia, Morris has spent years exploring the culture, history, and science of psychoactive substances. He continues this work today through his YouTube and Patreon channels. Check out our Merch⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow us on:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠,⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠,⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ For business inquiries contact: OtherworldTeam@unitedtalent.com If you have experienced something paranormal or unexplained, email us your story at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠stories@otherworldpod.com To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Please join us to experience the consciousness and healing energies of the InterGalactics to revitalize the endocrine system, hormones, and glands in our body.  Known as our inner pharmacopeia, the endocrine organs and hormones released by these glands are vital for our overall health and vitality.  We start out with a 50 minute healing session using all the downloaded InterGalactic Healing energies from all four levels to balance, heal, and revitalize the endocrine system.  We systematically go through the following endocrine glands:-Hypothalamus-Pituitary-Pineal-Thyroid-Parathyroid-Thymus-Pancreas-Adrenals-Testes/OvariesWe also balance all seven subtle body layers (physical, etheric, emotional, mental, causal, spiritual, and divine) as they relate to the endocrine system.

Watch BONUS episodes on Patreon: https://patreon.com/dannyjones Hamilton Morris is a journalist, documentarian, and scientific researcher. He is the creator of the VICE television series 'Hamilton's Pharmacopeia', in which he investigated the chemistry, history, and cultural impact of various psychoactive drugs. SPONSORS https://nordvpn.com/dannyjones ⬅ Exclusive Deal: Try risk-free w/ 30-day money back guarantee. https://hims.com/danny ⬅ Start your FREE online visit today. https://whiterabbitenergy.com/?ref=DJP ⬅ Use code DJP for 20% off. EPISODE LINKS Hamilton's YouTube - @HamiltonMorris https://www.patreon.com/HamiltonMorris https://www.instagram.com/hamiltonmorris FOLLOW DANNY JONES https://www.instagram.com/dannyjones https://twitter.com/jonesdanny OUTLINE 00:00 - Mr. Death 08:47 - Chaos: Charles Manson & CIA mind control 16:24 - US Military 'astrology computers' 25:21 - Kratom & substance dependency 35:26 - How Hamilton overcomes fear 38:09 - VICE early days & downfall 51:05 - Evolution of anti-drug propaganda 59:38 - What really causes addiction 01:06:22 - Ambien 01:09:05 - Fentanyl contamination in street drugs 01:17:21 - Haiti's zombie drug ritual 01:30:17 - The Sarlo Family Foundation 01:38:40 - Psychedelics in the church 01:44:57 - Ammon Hillman & the chemical muse 01:55:57 - The bicameral mind 02:01:41 - Venom as ancient vaccines 02:06:47 - DARPA psychedelic research 02:16:12 - DMT laser experiment 02:26:26 - Locked out of DMT? 02:32:57 - Doing toad venom DMT 02:34:50 - Nitrous oxide and Kayne West 02:46:04 - Xenon gas & methylene blue Learn more about your ad choices. Visit podcastchoices.com/adchoices

Is our time quickly becoming the era of “psychedelic McCarthyism”? If we're not careful, that's where it looks like we're heading… In this episode of The Psychedelic Report, Dr. Dave Rabin sits down with Hamilton Morris for an in-depth discussion on the recent controversy surrounding MDMA-assisted therapy and the FDA's pivotal August 9th decision. Together, they address the backlash against MAPS/Lykos and how misinformation has fueled public skepticism and prevented this safe and powerful treatment from getting to millions of patients suffering from PTSD. Hamilton shares his experience from evaluation and investigation of the MDMA clinical trials and sheds light on the media's tendency to sensationalize allegations, including claims of misconduct during the trials. Hamilton and Dr Rabin emphasize the importance of relying on the scientific method, evidence-based data, and research, rather than sensationalized narratives, when assessing the safety and efficacy of MDMA-assisted therapy.The conversation also explores the broader implications of the FDA's ruling and how the negative hype surrounding psychedelics has overshadowed their significant therapeutic benefits and is causing harm to patients in need. They call for a more balanced and responsible approach to discussing these therapies in both journalism and public discourse, advocating for truth and evidence over fear and speculation. This episode offers critical insights into the challenges facing psychedelic research today, highlighting the need for thoughtful engagement with the ongoing developments in this field.Instagram: https://www.instagram.com/hamiltonmorris/Hamilton's Pharmacopeia: https://www.vicetv.com/en_us/show/hamiltons-pharmacopeiaThe Hamilton Morris Podcast: https://hamiltonmorris.buzzsprout.com/1870388Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/

From a young age, Dr. Tieraona Low Dog has been deeply drawn to the natural world and the field of natural medicine. Her academic journey encompasses a diverse range of disciplines including massage therapy, martial arts, midwifery, and herbal medicine, before going to earn her medical degree from the University of New Mexico School of Medicine. She is the Founding Director of the Medicine Lodge Academy, and Dr. Low Dog served as a founding member of the  American Board of Physician Specialties' American Board of Integrative Medicine.  Her leadership extends to her tenure as Director of the first Inter-professional Fellowship in Integrative Health and Medicine, Fellowship Director for the University of Arizona's Center for Integrative Medicine that was founded by Andrew Weil, MD, and Co-Founder and guiding teacher for the New York Zen Center's Fellowship in Contemplative Medicine. She currently oversees the Fellowship of Integrative and Functional Medicine at the University of California-Irvine's Susan Samueli Integrative Health Institute. Recognized as a foremost authority in integrative medicine, women's health, dietary supplements, and herbal medicine, her scholarly work encompasses over 54 peer-reviewed scientific articles, 25 chapters in medical textbooks, and numerous authoritative books on health and medicine. Dr. Low Dog's global influence is highlighted by her participation in over 600 medical and scientific conferences worldwide. Dr. Low Dog has had a great impact on my professional work and it is an absolute honor to have her on the podcast today.  Together we discuss the incredible impact that she has had on both the holistic and traditional medicine communities and how she has effectively worked to bridge the gaps between herbal medicine and traditional medicine.  She reflects on the importance of continuing her education to expand her own knowledge and effectiveness and the power that comes with admitting that, even as a lifelong learner and practitioner, she doesn't know everything.  She also shares insights into the offerings from her Foundations in Herbal Medicine program and highlights the value of using herbs in clinical practice.  Together we discuss the dismal state of nutrition in America today and consider drug-nutrient interaction and depletion, strategies for effectively weaning patients off of PPIs, and the many plants and supplements that she recommends in achieving whole health and healing.  I'm your host, Evelyne Lambrecht, thank you for designing a well world with us. Key Takeaways: [3:16] From herbalist, midwife, and martial arts instructor to medical school student, Dr. Low Dog recalls the moment she realized the limits to what she could do without a medical degree.  [7:15] The importance of training clinicians and expanding practitioners' knowledge of botanical medicine. [11:16] Encouraging healing and creating change in the US healthcare system. [15:18] Bridging the gap between herbal medicine and traditional medicinal care. [21:00] Dr. Low Dog offers insights into the offerings from her Foundations in Herbal Medicine program. [23:32] Treating anxiety with nervings starts with considering how a patient views the world. [29:20] The value of storytelling when helping patients understand the value of plants in their healthcare. [34:14] Accurate dosing based on patient information and health profile. [38:16] Recommendations for herbs that are safe during pregnancy and breastfeeding. [42:47] The current state of nutritional health in the United States and the drug-nutrient interaction and depletion. [49:02] Dr. Low Dog's recommendations for transitioning patients off PPI's, including utilizing melatonin. [53:38] Dr. Low Dog shares what she has changed her mind about over her years of practice, her favorite supplements, and the health practices that keep her balanced.   Episode Resources: Dr. Tieraona Low Dog - https://www.drlowdog.com/ Medicine Lodge Academy - https://www.medicinelodgeranch.com/ U.S. Pharmacopeia - https://www.usp.org/ Design for Health Resources: Designs for Health - https://www.designsforhealth.com/ Visit the Designs for Health Research and Education Library which houses medical journals, protocols, webinars, and our blog. https://www.designsforhealth.com/research-and-education/education

In this episode, Paul F. Austin is joined by Hamilton Morris to explore bufotenin, psilomethoxin, and the nuances of psychedelic journalism. Find episode links, summary, and transcript here: https://thethirdwave.co/podcast/episode-226-hamilton-morris/ Recorded live at the 2023 Wonderland Conference in Miami, their conversation first explores both the science and historical perspective of lesser-mentioned compounds like bufotenine. Hamilton then shares his profound insights drawn from directing the acclaimed Vice TV docuseries Hamilton's Pharmacopeia, as well as his work as a psychedelic chemist. Together, Paul and Hamilton navigate the rich history, chemistry, and cultural impacts of various psychoactive drugs, touching on the wisdom from legends including Alexander Shulgin, Terrence McKenna, and more.   Highlights: The history of psilomethoxin and Hamilton's own experience with it. The limitations of reductionist approaches to understanding psychedelics. Exploring the well-documented history of bufotenine and its subjective effects. Hamilton's takeaways from working on Hamilton's Pharmacopeia. Hamilton on maintaining a balanced perspective in psychedelic journalism.   Links: Hamilton's podcast: https://www.patreon.com/HamiltonMorris Hamilton on Instagram: https://www.instagram.com/hamiltonmorris/?hl=en Hamilton on Twitter: https://twitter.com/hamiltonmorris?lang=en   Episode Sponsors: Magi Ancestral Supplements - Use coupon code TW10. Psyched Wellness - Use code THIRDWAVE23 to get 15% off. Magic Mind - Enjoy up to 56% off when applied to a 10-day subscription.

On this episode Matt sits down with Hamilton Morris. Hamilton is an American journalist, documentarian, and scientific researcher. He is the creator and director of the television series Hamilton's Pharmacopeia, in which he investigates the chemistry, history, and cultural impact of various psychoactive drugs. Morris frequently consults with media on the subject of psychoactive drugs and conducts pharmacological research at Saint Joseph's University in Philadelphia with an emphasis on the synthesis and history of dissociative anesthetics.       During the conversation the two discuss their fascination with psychedelics and their respective views on the experiences they elicit. After landing on the topic of Ketamine and how it's use has become more and more common in the psychedelic community, the two dive into a friendly debate on spirituality vs. materialism. While both Matt and Hamilton have explored the use of psychoactive molecules that have a tendency for creating out-of-body or "spiritual" experiences, the two have fundamentally differing views on what is occurring during these experiences. The conversation that ensues is nothing less than one of the best exchanges on the podcast to date. After the joust, they explore how Hamilton's filmmaking career began, his show Hamilton's Pharmacopeia, and what he will be working on in the future. This episode is a special one. Please enjoy! Find Hamilton: https://www.patreon.com/HamiltonMorris   https://www.youtube.com/@HamiltonMorris     Find Matt: https://www.instagram.com/xianarchive/   https://www.youtube.com/@XianArchive       Sponsored by Feel Free: https://botanictonics.com/   Use code 'Xian40' at checkout to save $40   --- Sponsored by SHEATH: https://sheathunderwear.com   Use code 'TIMEWHEEL' at checkout to save 20%.

In this evocative episode, we delve into the multidimensional life and works of Timothy Wyllie (1940-2017). This is a remaster of the conversation we had with him shortly before his death—it was just too important to leave in the vaults. We talk about angels, the Process, ketamine, PCP, UFOs, disembodied intelligences, and ALL KINDS of other WEIRD SH*T. You're gonna love it! From his roots in Great Britain and his education as an architect, to his pioneering explorations into out-of-body experiences, telepathic communications with dolphins, and profound interactions with nonphysical beings, Wyllie's journey is a testament to the vast potential of human experience. From ventures in New York City's business scene to his subsequent retirement into the world of creative endeavors, Wyllie was a fascinating and multifaceted individual, and listeners will be captivated by the blend of the tangible and ethereal in Wyllie's life. Timothy's unique "Bozon Music" — a harmonious fusion of True Age improvisational jazz and shamanic heartbeats — and his meditative guided visualizations offer a sonic glimpse into his spiritual psyche. Meanwhile, his intricate drawings of sacred landscapes serve as visual portals to sacred spaces. Throughout the episode, we'll explore the inspirations and aspirations that drove Wyllie's lectures, seminars, and writings, including his acclaimed books like "Ask Your Angels" and the "Rebel Angels" series. Join us on this enlightening journey as we celebrate the legacy of a man who seamlessly wove the fabric of the physical and spiritual worlds together. Show Notes Timothy Wyllie's Amazon Author Page Hamilton's Pharmacopeia episode with Timothy Wyllie Magick.Me

In this evocative episode, we delve into the multidimensional life and works of Timothy Wyllie (1940-2017). This is a remaster of the conversation we had with him shortly before his death—it was just too important to leave in the vaults. We talk about angels, the Process, ketamine, PCP, UFOs, disembodied intelligences, and ALL KINDS of other WEIRD SH*T. You're gonna love it! From his roots in Great Britain and his education as an architect, to his pioneering explorations into out-of-body experiences, telepathic communications with dolphins, and profound interactions with nonphysical beings, Wyllie's journey is a testament to the vast potential of human experience. From ventures in New York City's business scene to his subsequent retirement into the world of creative endeavors, Wyllie was a fascinating and multifaceted individual, and listeners will be captivated by the blend of the tangible and ethereal in Wyllie's life. Timothy's unique "Bozon Music" — a harmonious fusion of True Age improvisational jazz and shamanic heartbeats — and his meditative guided visualizations offer a sonic glimpse into his spiritual psyche. Meanwhile, his intricate drawings of sacred landscapes serve as visual portals to sacred spaces. Throughout the episode, we'll explore the inspirations and aspirations that drove Wyllie's lectures, seminars, and writings, including his acclaimed books like "Ask Your Angels" and the "Rebel Angels" series. Join us on this enlightening journey as we celebrate the legacy of a man who seamlessly wove the fabric of the physical and spiritual worlds together. Show Notes Timothy Wyllie's Amazon Author Page Hamilton's Pharmacopeia episode with Timothy Wyllie Magick.Me

In this episode, I talk with Gina Giorgio.Gina wears many hats within the psychedelic space as founder of the North Carolina Psychedelic Policy Coalition, the Director of the Students for Sensible Drug Policy (SSDP) Mentorship Pipeline, a Communications and Policy Specialist for NisonCo, a contributing writer for Psychedelic Spotlight, and the Founder and CEO of the Mushroom Lifestyle brand Smush.Our conversation covers topics like finding the balance between working in the psychedelic space and graduate school and how Gina started her own company by tapping into academic networks and resources.Gina also shares her journey from studying Psychology at High Point University to diving into her psychedelic interests with Hamilton's Pharmacopeia.We also discuss the ins and outs of policy related to psychedelics and cannabis, looking at what makes them similar yet unique.Throughout our conversation, Gina offers gems of advice for anyone interested in policy or communications work in the field.Finally, Gina reflects on her role in the psychedelic field and her interests in public education, policy development, and building her company, Smush.Time Stamps:(05:10) An overview of each of the companies Gina is involved with and her role at each of them (Students for Sensible Drug Policy, NisonCo, Psychedelic Spotlight, the North Carolina Psychedelic Policy Coalition)(10:52) How being a part of each organization has helped her reach her goal of working in the psychedelic field(16:05) Finding balance working in the psychedelic field and being a graduate student(21:10) The adventure of starting her own company, Smush and tapping into university resources(32:07) SSDP's Psychedelic Mentorship Pipeline(38:32) Fostering Gina's psychedelic interests from Hamilton's Pharmacopeia and the intricacies of psychedelic interests while in college(54:15) Cannabis work with NisonCo and similarities and differences with psychedelic policy development(1:07:58) Contemplating Gina's future academic routes and the value and challenges of getting a PhD(1:16:59) Final advice - mentorship(1:20:34) Gina's hopes for the future in public education and communication and building SmushLinks:SSDP Mentorship Pipeline: https://ssdp.org/our-work/psychedelic-pipeline/Curious to Serious with Vilmarie Fraguada Narloch: Spotify, Apple, GoogleNorth Carolina Psychedelic Policy Coalition: https://healingpolicy.org/Gina's Work at Psychedelic Spotlight:Rest and Restore: A Journey Into the Legal Entheogenic Ceremony Space in the U.S.: https://psychedelicspotlight.com/rest-and-restore-a-journey-into-the-legal-entheogenic-ceremony-space-in-the-u-s/5 Psychedelia Books Our Staff Loves: https://psychedelicspotlight.com/best-psychedelic-books-our-staff-loves/Smush: https://www.sm

Join some of the leading researchers who will share their perspectives on the future of psychedelic science. Those with decades of experience have knowledge that is crucial to finding the right paths forward as psychedelics go mainstream. The psychedelic science torch is getting passed to the next generation, with fresh perspectives on both ancient and future medicines. Can we take the “trip” out of psychedelics and do we want to? Will “next gen” psychedelic compounds have an advantage over today's medicines? Documentarian and researcher Hamilton Morris (Hulu's “Hamilton's Pharmacopeia”), pharmacology professor & Heffter Institute founder David Nichols, Psychiatry & Neuroscience professor Rachel Yehuda (Mt. Sinai) and Palo Santo's Tim Schlidt explore the future of psychedelic science.

Hamilton Morris is an American journalist, documentarian, and scientific researcher. He is the creator and director of the television series Hamilton's Pharmacopeia, in which he investigates the chemistry, history, and cultural impact of various psychoactive drugs. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit chrisryan.substack.com/subscribe

What's with the war on drugs? Are we setting an impossibly high standard for psychedelic medicine? Does law enforcement truly understand the psychedelic approach, or are they enforcing laws based on past misconceptions. Join me as I sit down with psychedelic detective Hamilton Morris of Hamilton's Pharmacopeia on VICE to explore the major issues and aspirations of the psychedelic frontier. Discover why psychedelics remain illegal, and how their potential to dissolve societal norms challenges the status quo. Tune in to this mind-expanding episode of The Psychedelic Report as we venture into the uncharted realms of psychedelic medicine.

In this episode of "The Top Line," we talk with Vimala Raghavendran, the vice president of informatics and product development at U.S. Pharmacopeia, about the factors causing the ongoing chemotherapy shortage. We also cover the Grail harassment lawsuits, CRISPR for Alzheimer's drug development, and the rest of the week's headlines.  To learn more about the topics in this episode: BridgeBio heart disease drug vindicated with phase 3 victory, plots FDA submission this year The Future of Biotech Grail sued by 3 women over alleged 'frat house' culture, harassment and retaliation Scientists turn CRISPR scissors to genes involved in Alzheimer's National cancer group reports widespread chemo shortages, calls on government and industry to help resolve them FDA to allow temporary overseas production to shore up supplies of chemo drug FDA can't solve drug shortages on its own, agency's oncology chief says "The Top Line" is produced by senior podcast producer Teresa Carey. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.See omnystudio.com/listener for privacy information.

Thanks for tuning into another Deep Share. On this episode, I continue my ongoing foray into psychedelica's dark underbelly. My guest is Carl Hassell, who has a lot of first hand experience with this subject, and quite a few first hand accounts of the shady characters and organizations surrounding and engulfing the psychedelic culture. We talk about Peyote Way Church of God, The Grateful Dead, Weaponized Anthropology, Mormon Splinter Groups, and some Laurel Canyon corrections as well. We also cover the NEW psychedelic revolution that's going on right now and what it could possibly be leading us into. This was a great conversation and Carl is an excellent guest and compassionate person. Hope you enjoy!Carl Hassell:https://twitter.com/CarlHassel98610 Thanks for checking out this episode of the Deep Share Podcast!https://linktr.ee/thedeepshareIf you'd like to support the Deep Share:https://app.redcircle.com/shows/df9fe83b-678c-4a21-8aad-ce78e59c75f2/donationsOr join me over on Patreon:www.patreon.com/thedeepshare/Support this podcast at — https://redcircle.com/thedeepsharepodcast/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Welcome to Thrive with Cate Stillman podcast, where we explore the ancient wisdom of Ayurveda and traditional healing practices. In this episode, we delve into the transformative power of Ayurvedic treatments like Panchakarma and Kaya Kalpa, with Greg Soucy and Bryan Miller, shedding light on their rejuvenating effects. We will also emphasize the significance of personal responsibility in the healing journey, inviting listeners to embark on a path of holistic well-being.   What You'll Get Out of Tuning In Discover the essence of Panchakarma and Kaya Kalpa, two powerful Ayurvedic therapies, and their role in restoring balance and vitality. Understand the importance of personal responsibility and active participation in the healing journey. Explore the concept of tapas and its significance in achieving deep healing and rejuvenation. Gain insights into the potential healing properties of practices like Panchakarma, psychedelics, and urine therapy.   Highlights Learn about the comprehensive detoxification and rejuvenation therapy known as Panchakarma and its advanced form, Kayakalpa. Hear personal experiences that highlight the profound physical and emotional effects of Panchakarma and Kayakalpa treatments. Explore the role of personal effort and commitment in the healing journey, and the importance of embracing discomfort for transformation. Discover the concept of Amrita, the nectar of immortality, and its potential connection to various healing practices.   Quotes "Panchakarma and Kayakalpa have the power to restore balance and vitality, creating a profound impact on our well-being." "True healing requires personal effort and commitment. Practitioners can assist, but the responsibility lies within ourselves." "Tapas, the practice of intense self-discipline, plays a significant role in achieving deep healing and rejuvenation." "Amrita, the nectar of immortality, is a concept that holds the potential for profound transformation and rejuvenation." Links Get access to Uplevel Your Life here. Use promo code: UPLEVELFREE Cate's latest book: Uninflamed: 21 Anti-Inflammatory PRIMAL HABITS to heal, sleep better, intermittent fast, detox, lose weight, feel great, & crush your life goals with a kickass microbiome Want to ask Cate a question for the podcast? Record it here: catestillman.com/ask Want a free personalized session: curious@clubthrive.global   In this episode, we explore the transformative power of Ayurveda and traditional healing practices, focusing on Panchakarma and Kaya Kalpa therapies. We discuss the importance of personal responsibility and tapas in the healing journey, along with the potential healing properties of practices like Panchakarma, psychedelics, and urine therapy. By tuning in, you'll gain insights into these ancient wisdom traditions and discover how they can restore balance, promote rejuvenation, and enhance personal growth.  

THUG DRUGS! With a name like that, it has to be good! Even better than Smuckers (Age old ad slogan for jelly/jam)! From OTC and prescription opioids to controlled substance opioids, Heroin to Oxy, the PAIN GUY on the PAIN POD will discuss legal and illicit opioids in the realms of pain management, substance use disorder (addiction), and our communities, and globe for that matter. Get ready for some homework, as you'll definitely end up watching American Pain, Dopesick, Drugs Inc., Hamilton's Pharmacopeia, and maybe even Lord of the Rings, wait, Lord of the Rings, yup, addiction, the entire time. Come one, come all, to the Pain Pod!!! Drug/Overdose Trends • https://www.drugabuse.gov/drug-topics/trends-statistics/overdose-death-rates • https://www.iqvia.com/insights/the-iqvia-institute/reports/prescription-opioid-trends-in-the-united-states Illicit Substances Resources • Erowid • DEA Reports o Drugs of Abuse o National Drug Threat Assessment • INCB (International Narcotics Control Board) • UNODC (United Nations Office on Drugs and Crime) • European Monitoring Centre for Drugs and Drug Addiction • CESAR (Center for Substance Abuse Research) • NIDA (National Institute on Drug Abuse) • Online Blogs o Blue Light o Drug Forum

THUG DRUGS! With a name like that, it has to be good! Even better than Smuckers (Age old ad slogan for jelly/jam)! From OTC and prescription opioids to controlled substance opioids, Heroin to Oxy, the PAIN GUY on the PAIN POD will discuss legal and illicit opioids in the realms of pain management, substance use disorder (addiction), and our communities, and globe for that matter. Get ready for some homework, as you'll definitely end up watching American Pain, Dopesick, Drugs Inc., Hamilton's Pharmacopeia, and maybe even Lord of the Rings, wait, Lord of the Rings, yup, addiction, the entire time. Come one, come all, to the Pain Pod!!! Drug/Overdose Trends • https://www.drugabuse.gov/drug-topics/trends-statistics/overdose-death-rates • https://www.iqvia.com/insights/the-iqvia-institute/reports/prescription-opioid-trends-in-the-united-states Illicit Substances Resources • Erowid • DEA Reports o Drugs of Abuse o National Drug Threat Assessment • INCB (International Narcotics Control Board) • UNODC (United Nations Office on Drugs and Crime) • European Monitoring Centre for Drugs and Drug Addiction • CESAR (Center for Substance Abuse Research) • NIDA (National Institute on Drug Abuse) • Online Blogs o Blue Light o Drug Forum

This week the multi-part RESCUE series continues with an examination of familiar products derived from the ocean that we use to support our ways of life, our well-being and our health: from vitamins and supplements to pain and cancer treatments. And we discuss the future of exploration and exploitation of resources as the bio-prospecting rush heats up. How are we regulating extraction from the ocean and seafloor? Who owns the proprietary rights to marine resources, and what criteria are applied to protect biodiversity, ocean ecosystems and future resource potential to revolutionize medicine and treat disease?

This week the multi-part RESCUE series continues with an examination of familiar products derived from the ocean that we use to support our ways of life, our well-being and our health: from vitamins and supplements to pain and cancer treatments. And we discuss the future of exploration and exploitation of resources as the bio-prospecting rush heats up. How are we regulating extraction from the ocean and seafloor? Who owns the proprietary rights to marine resources, and what criteria are applied to protect biodiversity, ocean ecosystems and future resource potential to revolutionize medicine and treat disease? About World Ocean Radio 5-minute weekly insights dive into ocean science, advocacy and education hosted by Peter Neill, lifelong ocean advocate and maritime expert. Episodes offer perspectives on global ocean issues and viable solutions, and celebrate exemplary projects. Available for syndicated use at no cost by college and community radio stations worldwide.World Ocean Radio offers five-minute weekly insights that dive into ocean science, advocacy and education, hosted by Peter Neill, Director of the W2O, author, and lifelong ocean advocate. Episodes offer perspectives on global ocean issues, today's challenges, marine science and policy, and exemplary solutions. Available for RSS feed, podcast, and syndicated use at no cost by community radio stations worldwide.

Mike has a conversation with Dr. Cole Marta and Brooke Balliett, LMFT of the California Center for Psychedelic Therapy. Recorded Sunday, April 2nd at the Center. Topics discussed include: Preparing set and setting for a psychedelic trip, dosage differences in individual people, Ego Death, surrendering to a trip, resistance, Creatives, sharpening by amphetamines, Alex Grey, the Community of trippers, experimenting with shrooms during COVID lockdowns, Ketamine use for preventing suicide, Ecstasy vs Molly, research chemicals, dancesafe.org, Schedule One Drug License, research pharmacies, variations in unregulated street drugs, regular doses, benefits of regulated drugs, clinical benefits for mental health patients, importance of set and setting, protecting friends from bad drugs, buying drugs online, Ketamine's similarity to Nitrous, Spiritual connection, Ketamine therapy cycle, belief in God, ancient use of psychedelics, Ancient Greeks, Salem Witch Trials, Ketamine primarily used to treat depression and PTSD, common ground of psychedelic trips and deep meditation states, Default Mode Network, changes in cognition/perspective/emotionality, visuals, psychedelic replications, Replications Sub Reddit, trippy dream of Ketamine high, new client intake, prep before treatment, submitting to the process, the power of getting started, center vs clinic, unsafe feeling resulting from trauma, pre-verbal trauma, Ketamine as anesthetic, MDMA's power to helping client feel safe, treating depression with psilocybin, “Being depressed is the opposite of being excited about being alive”, debilitating depression, spectrum of personality traits, Zendo, Burning Man, lack of guidance at raves, Adavan, duration of trips, staying up overnight on LSD, post-rave kit, inability to fall asleep, feeling a trip coming on, improved dancing ability, DJ RAW, raves as church, the body as a conduit for sound, fractals in nature, tapping into new levels of being, inability to understand language while on LSD, A-Ha moments/changing perspectives, seeing through cultural illusions, “Watching the news on acid is a bad idea”, DMT, feeling of immobility, short duration, NN (orange resin) vs 5MEO (frog venom), Hamilton's Pharmacopeia, 5MEO flashbacks, using cannabis and psilocybin as entry points to the psychedelic experience, tardigrades, importance of good sourcing, situational awareness while high, Erowid.org and FiresideProject.org. Psychedelictherapyca.com Givebutter.com/CCPT-TYL

Hamilton Morris is an American journalist, filmmaker and scientific researcher. Previously a writer for Vice magazine with a monthly column “Hamilton's Pharmacopeia”, Morris currently conducts pharmacological research at St. Joseph's University in Philadelphia. Interested in psychoactive substances and hallucinogens, Morris' interests overlap with those of ethnobotanist Dr. Mark Plotkin. In this second half of a two-part episode, Morris and Dr. Plotkin ponders synthetic versus organic psychedelics, microdosing and the magic of hallucinogens.

Hamilton Morris is an American journalist, filmmaker and scientific researcher. Previously a writer for Vice magazine with a monthly column “Hamilton's Pharmacopeia”, Morris currently conducts pharmacological research at St. Joseph's University in Philadelphia. Interested in psychoactive substances and hallucinogens, Morris' interests overlap with those of ethnobotanist Dr. Mark Plotkin. In this first half of a two-part episode, Morris and Dr. Plotkin ponder magic frogs, Iboga and the magic of hallucinogens.

In this episode, Joe interviews Soren Shade: producer of the third season of “Hamilton's Pharmacopeia" and Co-Founder of Top Tree Herbs, a kratom tea company dedicated to educating people about kratom and normalizing its use. www.psychedelicstoday.com

Hamilton Morris and Dr. Mark Plotkin — Exploring the History of Psychoactive Substances, Synthetic vs. Natural Options, Microdosing, 5-MeO-DMT, The “Drunken Monkey” Hypothesis, Timothy Leary's Legacy, and More | Brought to you by Athletic Greens all-in-one nutritional supplement and 5-Bullet Friday, my very own email newsletter. More on both below.Welcome to The Tim Ferriss Show, where it is usually my job to deconstruct world-class performers, to tease out their routines, habits, et cetera that you can apply to your own life. This time around, we have a very special edition featuring two of your favorite guests: Dr. Mark Plotkin and Hamilton Morris. Mark takes over my duties as host and interviews Hamilton for an episode of the Plants of the Gods podcast. You, my dear listeners, are hearing the audio before anyone else, so this is a Tim Ferriss Show exclusive. I've previously featured some of my favorite episodes from that show at tim.blog/plantsofthegods. These episodes cover a lot of fascinating ground.Who is Mark? Mark (@DocMarkPlotkin) is an ethnobotanist who serves as president of the Amazon Conservation Team, which has partnered with ~80 tribes to map and improve management and protection of ~100 million acres of ancestral rainforests. He is best known to the general public as the author of the book Tales of a Shaman's Apprentice, one of the most popular books ever written about the rainforest. His most recent book is The Amazon: What Everyone Needs to Know. You can find my interview with Mark at tim.blog/markplotkin. And the guest today is Hamilton Morris. Hamilton (@HamiltonMorris) is a chemist, filmmaker, and science journalist. A graduate of The New School, he conducts chemistry research at Saint Joseph's University. Hamilton is the writer and director of the documentary series Hamilton's Pharmacopeia, in which he explores the chemistry and traditions surrounding psychoactive drugs. You can find my most recent interview with him at tim.blog/hamilton. This is a tightly packed 60-minute interview. Mark and Hamilton cover the history of different psychoactive substances, Timothy Leary's legacy, the “drunken monkey” hypothesis, conservation, microdosing, the differences between 5-MeO-DMT and DMT, a disease that afflicts people who smoke enormous quantities of cannabis, causing them to vomit continuously and only find relief from their nausea by taking a hot shower (yes, really), the impact of the placebo effect, a synthetic vs. a natural product, the role of ritual, and much, much more. Please enjoy!*This episode is brought to you by Athletic Greens. I get asked all the time, “If you could use only one supplement, what would it be?” My answer is usually AG1 by Athletic Greens, my all-in-one nutritional insurance. I recommended it in The 4-Hour Body in 2010 and did not get paid to do so. I do my best with nutrient-dense meals, of course, but AG further covers my bases with vitamins, minerals, and whole-food-sourced micronutrients that support gut health and the immune system. Right now, Athletic Greens is offering you their Vitamin D Liquid Formula free with your first subscription purchase—a vital nutrient for a strong immune system and strong bones. Visit AthleticGreens.com/Tim to claim this special offer today and receive the free Vitamin D Liquid Formula (and five free travel packs) with your first subscription purchase! That's up to a one-year supply of Vitamin D as added value when you try their delicious and comprehensive all-in-one daily greens product.*This episode is also brought to you by 5-Bullet Friday, my very own email newsletter that every Friday features five bullet points highlighting cool things I've found that week, including apps, books, documentaries, gadgets, albums, articles, TV shows, new hacks or tricks, and—of course—all sorts of weird stuff I've dug up from around the world.It's free, it's always going to be free, and you can subscribe now at tim.blog/friday.*For show notes and past guests on The Tim Ferriss Show, please visit tim.blog/podcast.For deals from sponsors of The Tim Ferriss Show, please visit tim.blog/podcast-sponsorsSign up for Tim's email newsletter (5-Bullet Friday) at tim.blog/friday.For transcripts of episodes, go to tim.blog/transcripts.Discover Tim's books: tim.blog/books.Follow Tim:Twitter: twitter.com/tferriss Instagram: instagram.com/timferrissYouTube: youtube.com/timferrissFacebook: facebook.com/timferriss LinkedIn: linkedin.com/in/timferrissPast guests on The Tim Ferriss Show include Jerry Seinfeld, Hugh Jackman, Dr. Jane Goodall, LeBron James, Kevin Hart, Doris Kearns Goodwin, Jamie Foxx, Matthew McConaughey, Esther Perel, Elizabeth Gilbert, Terry Crews, Sia, Yuval Noah Harari, Malcolm Gladwell, Madeleine Albright, Cheryl Strayed, Jim Collins, Mary Karr, Maria Popova, Sam Harris, Michael Phelps, Bob Iger, Edward Norton, Arnold Schwarzenegger, Neil Strauss, Ken Burns, Maria Sharapova, Marc Andreessen, Neil Gaiman, Neil de Grasse Tyson, Jocko Willink, Daniel Ek, Kelly Slater, Dr. Peter Attia, Seth Godin, Howard Marks, Dr. Brené Brown, Eric Schmidt, Michael Lewis, Joe Gebbia, Michael Pollan, Dr. Jordan Peterson, Vince Vaughn, Brian Koppelman, Ramit Sethi, Dax Shepard, Tony Robbins, Jim Dethmer, Dan Harris, Ray Dalio, Naval Ravikant, Vitalik Buterin, Elizabeth Lesser, Amanda Palmer, Katie Haun, Sir Richard Branson, Chuck Palahniuk, Arianna Huffington, Reid Hoffman, Bill Burr, Whitney Cummings, Rick Rubin, Dr. Vivek Murthy, Darren Aronofsky, and many more.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Today's episode is all about the word “marijuana,” a term that many people might not realize is intertwined with a complicated, hurtful, and quite-frankly racist history. If you weren't aware of the weight the word “marijuana” carries — you're not alone, and this episode will help shed light on its convoluted past. Our series Weed Words is where each month we unpack a widely recognized but narrowly understood term or phrase related to cannabis. SHOW NOTES History of Marijuana, The Origins and the History of the Word Marijuana, The Pharmacopeia of USA in 1850, History of Cannabis, The Mysterious History of Marijuana, Reefer Madness Clip, NCSL Cannabis Overview Hosted by Ellen Lee Scanlon Sign up for our newsletter at dothepot.com Follow us: IG: @dothepot FB: @dothepot Pinterest: @dothepot LinkedIn: How to Do the Pot Twitter: @dothepot --- Send in a voice message: https://anchor.fm/htdtp/message

[12/30/21] In Hamilton's Pharmacopeia (VICE TV), Hamilton Morris interviews PCP chemists, explores DMT, and investigates hallucinogenic fish. He joins Ask Dr. Drew to share what he's learned about psychedelics & drug usage around the world. Hamilton Morris is an American journalist, documentarian, and scientific researcher. He is the creator and director of the television series Hamilton's Pharmacopeia, in which he investigates the chemistry, history, and cultural impact of various psychoactive drugs. Follow Hamilton Morris:  https://twitter.com/hamiltonmorris  https://instagram.com/hamiltonmorris [This episode originally aired on December 30, 2021] Ask Dr. Drew is produced by Kaleb Nation ( https://kalebnation.com) and Susan Pinsky (https://twitter.com/FirstLadyOfLove). SPONSORS • REFRAME – Since the beginning of the pandemic, nearly 1 in 5 Americans has reported consuming an unhealthy amount of alcohol, but only 10% of them are actually getting the help they need. Reframe is a neuroscience-based smartphone app that helps users cut back or quit drinking alcohol. Use the code DRDREW for 25% off your first month or annual subscription at https://drdrew.com/reframe • BLUE MICS – After more than 30 years in broadcasting, Dr. Drew's iconic voice has reached pristine clarity through Blue Microphones. But you don't need a fancy studio to sound great with Blue's lineup: ranging from high-quality USB mics like the Yeti, to studio-grade XLR mics like Dr. Drew's Blueberry. Find your best sound at https://drdrew.com/blue  • HYDRALYTE – “In my opinion, the best oral rehydration product on the market.” Dr. Drew recommends Hydralyte's easy-to-use packets of fast-absorbing electrolytes. Learn more about Hydralyte and use DRDREW25 at checkout for a special discount at https://drdrew.com/hydralyte  • ELGATO – Every week, Dr. Drew broadcasts live shows from his home studio under soft, clean lighting from Elgato's Key Lights. From the control room, the producers manage Dr. Drew's streams with a Stream Deck XL, and ingest HD video with a Camlink 4K. Add a professional touch to your streams or Zoom calls with Elgato. See how Elgato's lights transformed Dr. Drew's set: https://drdrew.com/sponsors/elgato/  THE SHOW: For over 30 years, Dr. Drew Pinsky has taken calls from all corners of the globe, answering thousands of questions from teens and young adults. To millions, he is a beacon of truth, integrity, fairness, and common sense. Now, after decades of hosting Loveline and multiple hit TV shows – including Celebrity Rehab, Teen Mom OG, Lifechangers, and more – Dr. Drew is opening his phone lines to the world by streaming LIVE from his home studio in California. On Ask Dr. Drew, no question is too extreme or embarrassing because the Dr. has heard it all. Don't hold in your deepest, darkest questions any longer. Ask Dr. Drew and get real answers today. This show is not a substitute for medical advice, diagnosis, or treatment. All information exchanged during participation in this program, including interactions with DrDrew.com and any affiliated websites, are intended for educational and/or entertainment purposes only.

Hamilton Morris has been writing and making documentaries about drugs and the people who make them for over a decade, delving into the relationships between chemicals, people and society. We discussed his outstanding TV series - Hamilton's Pharmacopeia - including his objectives and creative process, his efforts to challenge popular myths and misconceptions, and the chemists and filmmakers whom he most admires. Learn more about your ad-choices at https://www.iheartpodcastnetwork.comSee omnystudio.com/listener for privacy information.

Psilocybin, cannabinoids, and supply chains, oh my! This episode features Marshall Tyler, who moved from one of the top-performing cannabis edible companies in the USA to a new venture that's exploring psychedelic science with an emphasis on set and setting. We went through Marshall's career path, how he learned about this space, and what he wants people to know if they're thinking about trying mindset-altering substances for the first time. LINKS: Andrew Pham on Beyond Buds: https://open.spotify.com/episode/5VRpF0jvL2HQJZf4TAqABs?si=e0ac8decdbd14d6f Hamilton's Pharmacopeia on Hulu: https://www.hulu.com/series/hamiltons-pharmacopeia-ba51f4e6-df48-4278-b75f-38f0d6ae6734 Books by Terence McKenna: https://bookshop.org/lists/books-by-terence-mckenna Find Marshall's favorite Plus gummies at People's: https://shop.peoplescali.com/stores/peoples/brands/0f600871-4532-46b6-a75c-a3059dc2fafe Meet the Field Trip Health team (including Marshall!): https://www.fieldtriphealth.com/our-team

Ben and Kami talk about how they went from hating drugs to trying the most illegal kinds and the impact that substances have had on their parenting, perspective, and family life. LINKS How to Change your Mind https://www.amazon.com/dp/0735224153?ref=exp_fightfortogether_dp_vv_d Drug Use for Grown-Ups https://www.amazon.com/dp/1101981644?ref=exp_fightfortogether_dp_vv_d Fantastic Fungi Doc https://fantasticfungi.com/watch/ Hamilton's Pharmacopeia https://www.hulu.com/series/hamiltons-pharmacopeia-ba51f4e6-df48-4278-b75f-38f0d6ae6734 Coaching from Ben https://www.patreon.com/fightfortogether PODCAST https://anchor.fm/fightfortogether Buy the Album and Book [cheapest and most helpful for us] https://fightfortogether.bigcartel.com/ OUR BOOK on AMAZON: https://geni.us/2000MilesTogether Date Filmed November 30, 2021 --- Support this podcast: https://anchor.fm/fightfortogether/support

Hamilton Morris is a chemist and filmmaker. He is the creator of the Vice docu series Hamilton's Pharmacopeia and a current researcher at Philadelphia's University of Science. We discuss the opiate epidemic, the war on drugs, legalization, and psychedelics for the treatment of mental illness.

Soren Shade visits Brian in Pittsburgh bearing gifts: mature kratom leaves and a kratom plant the Top Tree Herbs greenhouse in West Virginia. This is the 2nd time the Hamilton’s Pharmacopeia producer and kratom entrepreneur has been on the podcast – the first time being #47. Brian chews kratom for the first time, and we … 63. Chewing Kratom Leaves with Soren Shade Read More » The post 63. Chewing Kratom Leaves with Soren Shade first appeared on Kratom Science.

In this episode, Joe sits down with chemist, filmmaker, and science journalist Hamilton Morris. They discuss his time at Vice, PCP, “Hamilton's Pharmacopeia,” 5-MeO-DMT, and working with perceived enemies for the greater good.  www.psychedelicstoday.com

PART ONE In Part 1 of a two-segment presentation, Dr. Kim discussed historical and legal background for medical cannabis and cannabis in general; mechanism of action; applications for pain and symptom management; the science behind cannabis for cancer care; relative safety issues; contraindications and monitoring; and some public health concerns. She defined cannabis, marijuana, hemp, and indicated various code names for recreational marijuana. Marijuana was criminalized and removed from the U.S. Pharmacopeia in 1941, Most recently, some states have legalized it both medically and recreationally. For medical purposes, there is a lot of variation in what states will allow. A concern has been about the presence of contaminants in many products. Based on current research, the science and the evidence are not where they could be ideally. She discussed marijuana and how it works, mentioning the endocannabinoid system. Different ways exist to act on that system. She described the entourage effect and how it functions.   D

I caught up with Caroline, & Wendy to talk about particle characterization in Pharma.We discussed...Caroline's and Wendy's background and RSSL 00:54What is particle characterization 02:16Why is particle size important for pharmaceutical formulations? 02:37How do you measure the particle size distribution? 04:29What are the common challenges when measuring particle sizes 07:12Is what is measured dependent on the client or the Pharmacopeia? 08:57And do you just measure the particle size of the drug/API? 10:30What are the current trends in this area? 13:06You can get more info at https://lnkd.in/gaaPTG4You can view this and the other RSSL #ChatsWithChaudhrey interviews on the #RSSL Play list on my YouTube Channel,

I spoke with Hamilton Morris, host and director of the Vice documentary series Hamilton's Pharmacopeia, which has hastened the revolution of drugs in the United States. Hamilton's podcast: https://www.patreon.com/HamiltonMorris RENEGADE UNIVERSITY WEEKEND IN TEXAS Featuring Scott Horton, Hotep Jesus, Cody Wilson, Deirdre McCloskey, and Jack The Perfume Nationalist: https://renegadeuniversity.com/product/renegade-weekend-texas/ UPCOMING RENEGADE UNIVERSITY WEBINARS: • A … Continue reading Unregistered 173: Hamilton Morris →

On today's episode we have psychedelic journalist and writer of Your Psilocybin Companion, Michelle Janikian. Together we talk about Michelle's passion for opening people's mind beyond the mainstream narrative about psychedelics. She provides an honest vulnerability in our discussion about her journey with mental health, the continued work, and how she learned to grow and find her strength. If you enjoyed today's podcast, then please subscribe, leave a review, or share this podcast with a friend! And, join the movement by becoming a part of the conscious objectors patreon. Your support is what powers this work and the larger societal change we are fighting towards! Let's continue to challenge our assumptions and grow together. Join the community here: https://www.patreon.com/user?u=54121384 Modern Anarchy Community: Instagram Facebook Patreon LINKS: Michelle's Website - https://www.michellejanikian.com/ Fruiting Bodies Collective - https://www.fruitingbodiescollective.com/ The Psychedelic Equity Project - https://www.gofundme.com/f/28iv86kkw0?utm_campaign=p_cp_url&utm_medium=os&utm_source=customer Multidisciplinary Association for Psychedelic Studies (MAPS) - https://maps.org/ USONA Institute - https://usonaclinicaltrials.org/ Esperanza Mazateca - https://www.esperanzamazateca.com/ Psychedelics Today - https://psychedelicstoday.com/ DoubleBlind Mag - https://doubleblindmag.com/ Hamilton's Pharmacopeia - https://www.vicetv.com/en_us/show/hamiltons-pharmacopeia Dr. Carl Hart - Drug Use for Grown-Ups https://drcarlhart.com/

In this episode, we talk about shit sandwiches, breathwork and meditation praxis, Hamilton's Pharmacopeia, hidden proof of spirituality, extraterestrial tourists, DMT (dimethyltryptamine) being produced in the lungs, Brian Wilson from the Beach Boys, Terrance McKenna, influencing plant growth, Cattle Decapitation, remote viewing the origins of the coronavirus, A Bugs Life as an analogy for Marxism, personal emotional responsibility, boxed breathing techniques, relaxation techniques, the power of silence, forgiveness, free will, magical voices, transmutation. https://www.patreon.com/FakeMagick https://linktr.ee/FakeMagick   Update: Upon further reading, the paper cited by Matt regarding COVID-19 being a leak form a lab was vapid bad information. Be sure to use discretion when we cite things, as we can often be wrong, and we try to recognize it when we are.

Hamilton Morris is the creator and host of the Vice TV documentary series "Hamilton's Pharmacopeia," now in its third season.

Send us a textHamilton Morris discusses his documentary series on psychoactive drugs: science, cultural impacts, and misconceptions.Topics Discussed:Origins of Hamilton's Pharmacopeia: Started as a column and web series to provide honest, science-based discussions on drugs, countering 1990s media stigma.Drug education and media bias: Traditional scare tactics fail; honest information fosters better relationships with substances, as seen in parallels with abstinence education.Methamphetamine misconceptions: Often stigmatized due to class differences, not pharmacology; similar to amphetamine, with FDA-approved uses for ADHD and obesity.Xenon gas as an anesthetic: A noble gas inducing euphoria via NMDA antagonism; harvested from air, it's expensive but potentially ideal for medical use.Ketamine and dissociatives: NMDA antagonists like ketamine offer rapid antidepressant effects; experiences are dose-dependent, from alcohol-like to visionary out-of-body states.Ibogaine in Bwiti rituals: Used for addiction treatment in Gabon; induces logical self-reflection, challenging Western views on psychedelics and spirituality.Drug regulation ideals: Advocate for freedom with quality controls, like food regulations; decriminalization alone lacks purity safeguards.Future projects: Shifting to chemistry research on psychedelics; highlights challenges in documentary production and value of synthesis education.Practical Takeaways:Educate yourself on drug pharmacology to cultivate safe, beneficial use patterns rather than relying on stigma-driven narratives.Consider dose and context when using substances, as effects vary greatly and responsible use can prevent harm.Recognize socioeconomic factors in drug perceptions to reduce prejudice and support harm reduction over criminalization.Support independent creators through platforms like Patreon to enable accurate, in-depth content on science topics.About the guest: Hamilton Morris is a filmmaker, journalist, and chemist who created the documentary series Hamilton's Pharmacopeia, exploring the chemistry, pharmacology, and culture of psychoactive substances*Not medical advice.Support the showAffiliates: Lumen device to optimize your metabolism for weight loss or athletic performance. Special sale Nov 10 - Dec 1: Lumen is half off ($599 → $299), and MINDMATTER gets another 15% off. AquaTru: Water filtration devices that remove microplastics, metals, bacteria, and more from your drinking water. Through link, get $100 off for AquaTru Carafe, Classic and Under the Sink Units, and $300 off Freestanding models. Seed Oil Scout: Find restaurants with seed oil-free options, scan food products to see what they're hiding, with this easy-to-use mobile app. KetoCitra—Ketone body BHB + electrolytes formulated for kidney health. Use code MIND20 for 20% off any subscription (cancel anytime) For all the ways you can support my efforts

Send us a textHamilton Morris discussing his documentary series on psychoactive drugs, their science, cultural impacts, and misconceptions.Topics Discussed:Origins of Hamilton's Pharmacopeia: Started as a column and web series to provide honest, science-based discussions on drugs, countering 1990s media stigma.Drug education and media bias: Traditional scare tactics fail; honest information fosters better relationships with substances, as seen in parallels with abstinence education.Methamphetamine misconceptions: Often stigmatized due to class differences, not pharmacology; similar to amphetamine, with FDA-approved uses for ADHD and obesity.Xenon gas as an anesthetic: A noble gas inducing euphoria via NMDA antagonism; harvested from air, it's expensive but potentially ideal for medical use.Ketamine and dissociatives: NMDA antagonists like ketamine offer rapid antidepressant effects; experiences are dose-dependent, from alcohol-like to visionary out-of-body states.Ibogaine in Bwiti rituals: Used for addiction treatment in Gabon; induces logical self-reflection, challenging Western views on psychedelics and spirituality.Drug regulation ideals: Advocate for freedom with quality controls, like food regulations; decriminalization alone lacks purity safeguards.Future projects: Shifting to chemistry research on psychedelics; highlights challenges in documentary production and value of synthesis education.*Not medical adviceSupport the showAffiliates: Lumen device to optimize your metabolism for weight loss or athletic performance. Special sale Nov 10 - Dec 1: Lumen is half off ($599 → $299), and MINDMATTER gets another 15% off. AquaTru: Water filtration devices that remove microplastics, metals, bacteria, and more from your drinking water. Through link, get $100 off for AquaTru Carafe, Classic and Under the Sink Units, and $300 off Freestanding models. Seed Oil Scout: Find restaurants with seed oil-free options, scan food products to see what they're hiding, with this easy-to-use mobile app. KetoCitra—Ketone body BHB + electrolytes formulated for kidney health. Use code MIND20 for 20% off any subscription (cancel anytime) For all the ways you can support my efforts

In this episode, we begin to discuss the complicated history of cannabis.  I will share the findings of cannabis from 10,000 years ago through the era of cannabis as medicine and then to the criminalization and demonization of the drug. We begin by looking at the ancient history of cannabis, the era of cannabis as medicine (1800s-1930s) when the U.S. Pharmacopeia had over 2000 cannabis preparations they could prescribe or patients could access. We look at hemp as an important player in our economy and how financial controls play a role in ultimately the criminalization of cannabis. Lastly but most importantly both episodes share the impact that cannabis criminalization has had on already marginalized communities and the incarceration rates of African Americans, Hispanics, and other POC communities. We look at the divisive and racist propaganda, incarcerations and financial impact that cannabis and the legal systems have used to keep these communities in the margins. Cannabis at the time of this recording a Schedule 1 drug at the federal level and not considered for medical use. This level of restriction has made it difficult to continue the research necessary to create greater gains in cannabis medicine. However, we continue to champion on and the government begins to take note of the ever-changing green rush. In this episode, we talk about the first ancient findings of cannabis as medicine and take a look at the history of cannabis from 10,200 years ago up to 1980. (Episode 4 will take a look at the years 1980-2019) Cannabis as medicine Reefer Madness Campaign Marijuana Tax Act Criminalization of cannabis for non-violent offenses Historical data, research and findings showing cannabis as safe all ignored Connect WIth Sandra Guynes www.facebook.com www.instagram.com/thekushnurse Join The Conversation The Kush Nurse Facebook Page The Kush Nurse Listen to the show on all platforms Apple Podcasts Google Play Spotify  

Hamilton Morris is a journalist and scientific researcher known for his documentaries, particularly those in the series Hamilton's Pharmacopeia, which is available through iTunes, Google Play, Hulu, and more. He has also written a number of articles for Harpers, which can be found here: https://harpers.org/author/hamiltonmorris/ In this episode we cover a range of topics, from atypical hallucinogens to the US government's experiments with psychoactive chemical weapons. Morris is also active on Twitter (http://twitter.com/hamiltonmorris). ---- How you can support TDC: https://thedrugclassroom.com/support/ ---- Music credit: Lee Rosevere (BY)

Hamilton Morris is a writer, documentarian, psychonaut and scientific researcher. His show "Hamilton's Pharmacopeia" is available on VICELAND.